Moleculin Biotech (MBRX) EBIT (QoQ) (2016 - 2025)
Moleculin Biotech (MBRX) EBIT (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Moleculin Biotech | 3.35 Mn | 3.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.55% |
| Sep 30, 2025 | -3.25% |
| Jun 30, 2025 | 3.75% |
| Mar 31, 2025 | 10.54% |
| Dec 31, 2024 | 6.90% |
| Sep 30, 2024 | -15.36% |
| Jun 30, 2024 | 7.37% |
| Mar 31, 2024 | 25.14% |
| Dec 31, 2023 | -49.97% |
| Sep 30, 2023 | 7.24% |
| Jun 30, 2023 | 23.26% |
| Mar 31, 2023 | -18.53% |
| Dec 31, 2022 | 22.41% |
| Sep 30, 2022 | -22.20% |
| Jun 30, 2022 | -5.09% |
| Mar 31, 2022 | -35.91% |
| Dec 31, 2021 | 15.46% |
| Sep 30, 2021 | -11.60% |
| Jun 30, 2021 | 9.38% |
| Mar 31, 2021 | -74.19% |